cleaving < clinical < clinicians

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]

Ident.	Authors (with country if any)	Title
000009 (2020)	C B Wu [République populaire de Chine] ; H Y Zhang [République populaire de Chine] ; S H Shao [République populaire de Chine] ; L W Dou [République populaire de Chine] ; Q Y Zhou [République populaire de Chine] ; Y. Liu [République populaire de Chine] ; W B Gao [République populaire de Chine] ; J H Zhu [République populaire de Chine]	[A report of six TAFRO syndrome: clinical characteristics, diagnosis and treatment analysis].
000012 (2020)	Seoyoung C. Kim [États-Unis] ; Sebastian Schneeweiss [États-Unis]	When Randomized Clinical Trials and Real-World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety.
000014 (2020)	Puja Mehta ; Jessica J. Manson	What Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
000058 (2020)	Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Nami Okamoto [Japon] ; Takahiro Yasumi [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Yuka Okura [Japon] ; Noriko Kinjo [Japon] ; Tomohiro Kubota [Japon] ; Yasuo Nakagishi [Japon] ; Kenichi Nishimura [Japon] ; Mariko Mohri [Japon] ; Masato Yashiro [Japon] ; Junko Yasumura [Japon] ; Hiroyuki Wakiguchi [Japon] ; Masaaki Mori [Japon]	Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
000072 (2020)	Rakesh Awasthi [États-Unis] ; Lida Pacaud [États-Unis] ; Edward Waldron [États-Unis] ; Constantine S. Tam [Australie] ; Ulrich J Ger [Autriche] ; Peter Borchmann [Allemagne] ; Samantha Jaglowski [États-Unis] ; Stephen Ronan Foley [Canada] ; Koen Van Besien [États-Unis] ; Nina D. Wagner-Johnston [États-Unis] ; Marie José Kersten [Pays-Bas] ; Stephen J. Schuster [États-Unis] ; Gilles Salles [France] ; Richard T. Maziarz [États-Unis] ; Özlem Anak [États-Unis] ; Christopher Del Corral [États-Unis] ; Jufen Chu [États-Unis] ; Irina Gershgorin [États-Unis] ; Iulian Pruteanu-Malinici [États-Unis] ; Abhijit Chakraborty [États-Unis] ; Karen Thudium Mueller [États-Unis] ; Edmund K. Waller [États-Unis]	Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL
000076 (2020)	Philip George [Nouvelle-Zélande] ; Nathaniel Dasyam [Nouvelle-Zélande] ; Giulia Giunti [Nouvelle-Zélande] ; Brigitta Mester [Nouvelle-Zélande] ; Evelyn Bauer [Nouvelle-Zélande] ; Bethany Andrews [Nouvelle-Zélande] ; Travis Perera [Nouvelle-Zélande] ; Tess Ostapowicz [Nouvelle-Zélande] ; Chris Frampton [Nouvelle-Zélande] ; Peng Li [République populaire de Chine] ; David Ritchie [Australie] ; Catherine M. Bollard [États-Unis] ; Ian F. Hermans [Nouvelle-Zélande] ; Robert Weinkove [Nouvelle-Zélande]	Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE)
000083 (2020)	Wen Zhang [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Fengchun Zhang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Taisheng Li [République populaire de Chine] ; Zhengyin Liu [République populaire de Chine] ; Jinglan Wang [République populaire de Chine] ; Yan Qin [République populaire de Chine] ; Xuan Zhang [République populaire de Chine] ; Xiaowei Yan [République populaire de Chine] ; Xiaofeng Zeng [République populaire de Chine] ; Shuyang Zhang [République populaire de Chine]	The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China
000096 (2020)	Tung-Hung Su [Taïwan] ; Jia-Horng Kao [Taïwan]	The clinical manifestations and management of COVID-19-related liver injury
000154 (2020)	Marc L. Chretien [Canada] ; David G. Bailey [Canada] ; Linda Asher [Canada] ; Jeremy Parfitt [Canada] ; David Driman [Canada] ; Jamie Gregor [Canada] ; George K. Dresser [Canada]	Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study
000156 (2020)	Shuichiro Nakabo [Japon] ; Yuko Tsuji [Japon] ; Maiko Inagaki [Japon] ; Hideaki Tsuji [Japon] ; Toshiki Nakajima [Japon] ; Kosaku Murakami [Japon] ; Chikashi Terao [Japon] ; Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] ; Yasutomo Fujii [Japon]	Severe joint deformity and Patient Global Assessment of Disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients.
000166 (2020)	Elyes Bouajina [Tunisie] ; Leith Zakraoui [Tunisie] ; Montassar Kchir [Tunisie] ; Samir Kochbati [Tunisie] ; Sofiene Baklouti [Tunisie]	Safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in Tunisian patients with active rheumatoid arthritis and inadequate response to disease-modifying anti-rheumatic drugs in conditions close to clinical practice.
000231 (2020)	Katie Bechman [Royaume-Uni] ; Mark Yates [Royaume-Uni] ; Sam Norton [Royaume-Uni] ; Andrew P. Cope [Royaume-Uni] ; James B. Galloway [Royaume-Uni]	Placebo Response in Rheumatoid Arthritis Clinical Trials.
000237 (2020)	Zaid H. Temrikar [États-Unis] ; Satyendra Suryawanshi [États-Unis] ; Bernd Meibohm [États-Unis]	Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients
000249 (2020)	Mark P. Lythgoe [Royaume-Uni] ; Paul Middleton [Royaume-Uni]	Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
000267 (2020)	Emanuele Nicastri ; Nicola Petrosillo ; Tommaso Ascoli Bartoli ; Luciana Lepore ; Annalisa Mondi ; Fabrizio Palmieri ; Gianpiero D Ffizi ; Luisa Marchioni ; Silvia Murachelli ; Giuseppe Ippolito ; Andrea Antinori	National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
000275 (2020)	Michele Russell-Westhead [Royaume-Uni] ; Nicola O Rien [Royaume-Uni] ; Iain Goff [Royaume-Uni] ; Elizabeth Coulson [Royaume-Uni] ; Jess Pape [Royaume-Uni] ; Fraser Birrell [Royaume-Uni]	Mixed methods study of a new model of care for chronic disease: co-design and sustainable implementation of group consultations into clinical practice
000314 (2020)	Amit Rout [États-Unis] ; Ajaypaul Sukhi [États-Unis] ; Rahul Chaudhary [États-Unis] ; Kevin P. Bliden [États-Unis] ; Udaya S. Tantry [États-Unis] ; Paul A. Gurbel [États-Unis]	Investigational drugs in phase II clinical trials for acute coronary syndromes.
000326 (2020)	Phillip Sommer ; Elvedin Lukovic [États-Unis] ; Eliot Fagley [États-Unis] ; Dustin R. Long [États-Unis] ; Julia B. Sobol [États-Unis] ; Katherine Heller ; Vivek K. Moitra [États-Unis] ; Ronald Pauldine [États-Unis] ; Michael F. O Onnor ; Sajid Shahul ; Mark E. Nunnally ; Avery Tung	Initial Clinical Impressions of the Critical Care of COVID-19 Patients in Seattle, New York City, and Chicago
000357 (2020)	Zaiwei Song [République populaire de Chine] ; Yang Hu [République populaire de Chine] ; Siqian Zheng [République populaire de Chine] ; Li Yang [République populaire de Chine] ; Rongsheng Zhao [République populaire de Chine]	Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience
000389 (2020)	Koichi Nakamura ; Tomoki Nakamura ; Takahiro Iino ; Tomohito Hagi ; Kouji Kita ; Kunihiro Asanuma ; Akihiro Sudo	Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
000391 (2020)	Slobodan M. Jankovic [Serbie] ; Izet Masic [Bosnie-Herzégovine]	Evaluation of Preclinical and Clinical Studies Published in Medical Journals of Bosnia and Herzegovina: Methodology Issues

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "clinical" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "clinical" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    clinical
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021